Abstract
Introduction
The use of scalp cooling for the prevention of chemotherapy-induced alopecia (CIA) is increasing. Cold caps are placed onto the hair-bearing areas of the scalp for varying time periods before, during, and after cytotoxic chemotherapy. Although not yet reported, improper application procedures could result in adverse events (AEs). At present, there are no evidence-based scalp cooling protocols, and there is no regulatory oversight of their use.
Objective
To report the occurrence of cold thermal injury (frostbite) on the scalp, following the use of cold caps for the prevention of CIA.
Materials and methods
We identified four patients who developed cold thermal injuries on the scalp following the application of cold caps. Medical records were analyzed to retrieve the demographic and clinical characteristics.
Results
The cold thermal injuries in our patients were grade 1/2 in severity and improved with topical interventions and interruption of cold cap use, although grade 1 persistent alopecia ensued in 3 patients. The true incidence of such injuries in this setting, however, remains unknown.
Conclusions
Cold thermal injuries are likely infrequent and preventable AEs that may result from improper device application procedures during cold cap use. Although these untoward events are usually mild to moderate in severity, the potential occurrence of long-term sequelae (e.g., permanent alopecia and scarring) or the need to discontinue cold cap use, are not known. Prospective studies are needed to further elucidate the risk and standardize healthcare delivery methods, and to improve patient/supportive/healthcare provider education.
Abbreviations
- AC-T:
-
Adriamycin + cyclophosphamide + paclitaxel
- AE:
-
Adverse event
- CIA:
-
Chemotherapy-induced alopecia
- CMF:
-
Cyclophosphamide + methotrexate + fluorouracil
- MSKCC:
-
Memorial Sloan Kettering Cancer Center
- PH:
-
Pertuzumab + trastuzumab
- TCHP:
-
Docetaxel + carboplatin + trastuzumab + pertuzumab
References
Stevens DM, D’Angelo JV (1978) Frostbite due due to improper use of frozen gel pack. N Engl J Med 299:1415
Quist LH, Peltier G, Lundquist KJ (1996) Frostbite of the eyelids following inappropriate application of ice compresses. Arch Ophthalmol 114:226
Graham CA, Stevenson J (2000) Frozen chips: an unusual cause of severe frostbite injury. Br J Sports Med 34:382–383
Sohatee MA, Brierley NA, Muir T (2014) “Salt ice dare”: a previously un-described mechanism of rapid frostbite injury. J Plast Reconstr Aesthet Surg 67:e248–e249
Brown WC, Hahn DB (2009) Frostbite of the feet after cryotherapy: a report of two cases. J Foot Ankle Surg 48:577–580
Oksuz S, Eren F, Sever C et al (2014) Frostbite injury of the breast: a case report. Ann Burns Fire Disasters 27:105–106
Wegener EE, Barraza KR, Das SK (1991) Severe frostbite caused by Freon gas. South Med J 84:1143–1146
Orlov AN, Dmitrienko OD (1990) Kozulin DA [severe frostbite of rare location]. Vestn Khir Im I I Grek 144:76–77
Luce JK, Raffetto TJ, Crisp IM et al (1973) Prevention of alopecia by scalp cooling of patients receiving adriamycin. Cancer Chemother Rep Part 1(57):108–109
Edelstyn GA, MacDonald M, MacRae KD (1977) Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet 2:253–254
Bulow J, Friberg L, Gaardsting O et al (1985) Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 45:505–508
Peck HJ, Mitchell H, Stewart AL (2000) Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 4:246–248
Katsimbri P, Bamias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 36:766–771
U.S. Food and Drug Administration. FDA allows marketing of cooling cap to reduce hair loss during chemotherapy (12/8/2015). Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm476216.htm. Accessed 18 Jan 2016
Rugo HS, Klein P, Melin SA et al (2015) Clinical performance of the DigniCap system, a scalp hypothermia system, in preventing chemotherapy-induced alopecia. ASCO Meeting Abstr 33:9518
Grevelman EG, Breed WP (2005) Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 16:352–358
Kadakia KC, Rozell SA, Butala AA et al (2014) Supportive cryotherapy: a review from head to toe. J Pain Symptom Manag 47:1100–1115
Mills W (2014) Clinical aspects of freezing cold injuries. In: Pandolf K, Burr R (eds) Medical aspects of harsh environments. Office of the Surgeon General, Falls Church, p 444
Bourne MH, Piepkorn MW, Clayton F et al (1986) Analysis of microvascular changes in frostbite injury. J Surg Res 40:26–35
Heggers JP, Robson MC, Manavalen K et al (1987) Experimental and clinical observations on frostbite. Ann Emerg Med 16:1056–1062
Bracker M (1992) Environmental and thermal injury. Clin Sports Med 11:419–436
Manson PN, Jesudass R, Marzella L et al (1991) Evidence for an early free radical-mediated reperfusion injury in frostbite. Free Radic Biol Med 10:7–11
Goertz O, Baerreiter S, Ring A et al (2011) Determination of microcirculatory changes and angiogenesis in a model of frostbite injury in vivo. J Surg Res 168:155–161
Auerbach LJ, Galvez MG, De Clerck BK et al (2013) A novel mouse model for frostbite injury. Wilderness Environ Med 24:94–104
Rothenberger J, Held M, Jaminet P et al (2014) Development of an animal frostbite injury model using the Goettingen-Minipig. Burns 40:268–273
Komen MM, Breed WP, Smorenburg CH et al (2016) Results of 20-versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 1–7
Acknowledgments
We thank Ms. Bernadette Murphy for the clinical photography. M.E.L. and V.R.B are supported by the RJR Oncodermatology Fund at Memorial Sloan Kettering Cancer Center. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MEL has consulting agreements with Dignitana and Paxman and receives research funding from Berg pharmaceuticals, KC has consulting agreements with Roche, Amgen, and PER. The other authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Belum, V.R., de Barros Silva, G., Laloni, M.T. et al. Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia. Breast Cancer Res Treat 157, 395–400 (2016). https://doi.org/10.1007/s10549-016-3799-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-3799-7